Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SEMLER SCIENTIFIC, INC.

(SMLR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Sell: Semler Scientific

10/13/2021 | 04:17pm EST


© MT Newswires 2021
All news about SEMLER SCIENTIFIC, INC.
11/23SEMLER SCIENTIFIC : November 2021 Presentation 2.2 MB
PU
11/18SEMLER SCIENTIFIC : November 2021 Presentation 2.2 MB
PU
11/05SEMLER SCIENTIFIC, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
11/02AFTER HOURS WATCH LIST SCORECARD : Anet, smlr, chgg
MT
11/02Lake Street Adjusts Semler Scientific PT to $175 From $200, Maintains Buy Rating
MT
11/02B. Riley Lowers Semler Scientific's Price Target to $145 From $175 After Q3 Results Mis..
MT
11/01MT NEWSWIRES AFTER HOURS WATCH LIST : Anet, smlr, chgg
MT
11/01Semler Scientific Reports Lower Q3 Net Income Despite Growth in Revenue
MT
11/01Semler Reports Third Quarter and Year-to-Date 2021 Financial Results - Form 8-K
PU
11/01Semler Scientific, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
More news
Analyst Recommendations on SEMLER SCIENTIFIC, INC.
More recommendations
Financials (USD)
Sales 2021 55,0 M - -
Net income 2021 19,3 M - -
Net cash 2021 40,2 M - -
P/E ratio 2021 40,9x
Yield 2021 -
Capitalization 653 M 653 M -
EV / Sales 2021 11,1x
EV / Sales 2022 8,63x
Nbr of Employees 86
Free-Float 70,8%
Chart SEMLER SCIENTIFIC, INC.
Duration : Period :
Semler Scientific, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 96,56 $
Average target price 167,33 $
Spread / Average Target 73,3%
EPS Revisions
Managers and Directors
Douglas R. Murphy-Chutorian Chief Executive Officer, Secretary & Director
Andrew B. Weinstein Senior Vice President-Finance & Accounting
Robert G. McRae Chief Technical Officer
Wayne T. Pan Independent Director
Arthur N. Leibowitz Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SEMLER SCIENTIFIC, INC.2.72%653
MASIMO CORPORATION5.88%15 691
GETINGE AB100.52%11 520
NOVOCURE LIMITED-43.94%10 072
PENUMBRA, INC.42.95%9 346
SHOCKWAVE MEDICAL, INC.77.02%6 482